Navigation Links
Isotechnika's Lead Drug, ISA247, To Be Highlighted at the,Association for Research in Vision and Ophthalmology (ARVO) Annual,Meeting

cessful, seek regulatory approval for LX211 in late 2008.”

Dr. Randall Yatscoff, Isotechnika’s President & CEO commented, “We are encouraged by the preclinical data seen to date and we look forward to working with Lux Biosciences to facilitate meeting their clinical development timelines. Uveitis is the third indication that ISA247 (LX211) is currently being developed for. Late-stage clinical trials are also being conducted with ISA247 for the treatment of moderate to severe psoriasis and the prevention of kidney graft rejection.”

-30-

For More Information:

Dr. Randall Yatscoff Stephanie Gillis-Paulgaard

President & CEO Director, Corporate Communications

Isotechnika Inc. Isotechnika Inc.

780-487-1600 (247) 780-909-4661

780-484-4105 (fax) 780-484-4105 (fax)

ryatscoff@isotechnika.com sgillis-paulgaard@isotechnika.com

About Isotechnika

Edmonton-based Isotechnika Inc. is an international biopharmaceutical company focused on the discovery and development of novel immunosuppressive therapeutics that are safer than currently available treatments. Isotechnika looks to become the leader in development of immunosuppressant therapies.

Isotechnika's lead drug, ISA247, has successfully completed a Phase 3 Canadian trial for the treatment of moderate to severe psoriasis. ISA247 is currently being investigated in a combined Phase 3 European/Canadian psoriasis trial and a Phase 2b North American trial for the prevention of kidney graft rejection. On
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Isotechnikas independent data monitoring committee conducts review of phase 2b kidney transplant trial
2. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
3. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
4. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
5. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
6. Gentiums Defibrotide Highlighted in Two Poster Presentations at American Association for Cancer Research Annual Meeting
7. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
8. NIEHS Researchers Identify Enzyme Critical in DNA Replication
9. Stanford Researchers Find Brain Pathway of Depression in Rats
10. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
11. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
Post Your Comments:
(Date:12/22/2014)... 22, 2014 NxStage Medical, Inc. (NASDAQ: ... dialysis products, announced today that the U.S. Food ... One™ to perform hemodialysis overnight while the patient ... hemodialysis. NxStage,s® System One is the first and ... this indication. Home nocturnal hemodialysis ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... the "US Self-monitoring Blood Glucose Market" report ... This market insight focuses on the ... the United States . Reimbursement analysis and ... product analyses for more than 73 SMBG meters have ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3US Self-monitoring Blood Glucose Market 2Investment Analysis of the US Medical Device Sector 2
... Pa., Feb. 27, 2012 Auxilium Pharmaceuticals, Inc. (Nasdaq: ... participate in the 2012 Cowen Healthcare Conference to be ... in Boston.  Mr. Jim Fickenscher, Chief Financial Officer, is ... its product pipeline at 9:20 a.m. ET on Tuesday, ...
... (Pink Sheets: TROV.PK), a developer of trans-renal molecular diagnostics, ... to expand its business development activities and monetize the ... "Trovagene owns a significant portfolio of molecular diagnostic intellectual ... applications. While the company will focus its internal R&D ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference 3Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference 4Trovagene Expands Business Development Efforts Through a Partnership with Leomics Associates, Inc. 2Trovagene Expands Business Development Efforts Through a Partnership with Leomics Associates, Inc. 3
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... illnesses can receive effective, less expensive care from a clinic ... a team of dedicated health care professionals, a new study ... and need either hospitalization or a trip to the emergency ... clinic at the University of Texas in Houston versus usual ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- Overeating is common ... you eat in moderation, an expert says. "Don,t arrive ... up calories if you know you,ll be attending a party, ... Jill Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount ... better to eat healthy during the day and even to ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 ... "fountain of youth" drug that can delay the effects of ... study suggests. Seniors received a significant boost to their ... signaling pathway linked to aging and immune function, researchers with ... medication, a version of the drug rapamycin, improved the seniors, ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number of ... District of West Virginia, Bernstein Liebhard LLP reports. According ... Court is scheduled to convene a Joint Status Conference ... at 10:00 a.m. Parties have been directed to submit ...
(Date:12/25/2014)... Plugin creators from Pixel Film Studios ... customizable business presentation tool made specifically for Final ... business tool, users can now display their stats and ... Film Studios. “ProFire 5k gives users a multiple options ... to a presentation” , Pixel Film Studios takes the ...
Breaking Medicine News(10 mins):Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... provides blueprint to fight the environmental triggers of,childhood asthma, ... and neighborhoods are riddled with preventable asthma triggers,that leave ... report released,today by PolicyLink and The California Endowment lays ... make our children,s air safer and healthier., The ...
... 13, 2008 Individuals with autism spectrum disorders ... communications, and display repetitive behaviors and abnormal responses ... autistic childs impaired social abilities is their lack ... and hugging that strengthen social bonds. On ...
... FRANCISCO, May 13 Medivation, Inc.,(Nasdaq: MDVN ) today announced ... the following conferences., -- Rodman & Renshaw 5th Annual ... at 2:40 p.m. local time at Le Meridien Beach Plaza Hotel ... Specialty and Generic Pharmaceuticals Conference on Wednesday, ...
... HARBIN, China, May 13 /Xinhua-PRNewswire-FirstCall/ -- China Sky ... Company,) (OTC Bulletin,Board: CSKI), a leading fully integrated ... People,s Republic of China,("PRC"), today announced that the ... & Co. All-Cap All-China Conference on May 19, ...
... note doses of the blood-pressure drugs given in the study ... -- Patients who received the blood pressure-lowering drugs known as ... of dying or having a stroke, a new Canadian study ... likely to have a heart attack, according to the report ...
... 13 EntreMed, Inc.,(Nasdaq: ENMD ) a ... cancer and inflammatory diseases,announced today that James S. ... Company overview at the Rodman and Renshaw 5th ... Le Meridien Beach Plaza Hotel in,Monte Carlo, May ...
Cached Medicine News:Health News:Why Our Kids Can't Breathe in Our Communities 2Health News:Why Our Kids Can't Breathe in Our Communities 3Health News:Genetic links to impaired social behavior in autism 2Health News:Medivation Announces Participation in Upcoming Conferences 2Health News:China Sky One Medical, Inc. to Present at Brean Murray Carret & Co. All-Cap All-China Conference 2Health News:Beta Blockers Raise Stroke, Death Risk After Surgery 2Health News:Beta Blockers Raise Stroke, Death Risk After Surgery 3Health News:EntreMed to Present at The Rodman and Renshaw 5th Annual Global Healthcare Conference 2
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The upper body blanket covers the upper torso, arms, neck, and head of the patient....
The Electri-Cool® II is the premier choice when it comes to localized cold therapy systems. system offers the widest variety of application-specific pads and wraps, for your convenience....
Complete Cataract Competence , OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today....
Medicine Products: